Cencora to Acquire Majority Stake in OneOncology from TPG

December 15, 2025

Cencora, Inc. entered into a definitive agreement to acquire the majority of the outstanding equity interests it does not already own in OneOncology from TPG and other shareholders. The transaction is valued at an enterprise value of $7.4 billion, with expected close by the end of Cencora’s fiscal 2026 second quarter subject to customary regulatory approvals.

Buyers
Cencora, Inc.
Targets
OneOncology
Sellers
TPG, Other shareholders of OneOncology
Location
Tennessee, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.